Viewing StudyNCT01399593



Ignite Creation Date: 2024-05-05 @ 11:42 PM
Last Modification Date: 2024-10-26 @ 10:38 AM
Study NCT ID: NCT01399593
Status: TERMINATED
Last Update Posted: 2017-10-03
First Post: 2011-07-19

Brief Title: Safety Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
Sponsor: Alexion Pharmaceuticals Inc
Organization: Alexion Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Antibody Mediated Rejection
Keywords:
Name View
Kidney Transplant View
Antibody Mediated Rejection View
AMR View
Acute Humoral Rejection View
AHR View
Living Donor View